Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. markets closed

S&P 500
5,969.34
+20.63(+0.35%)
Dow 30
44,296.51
+426.16(+0.97%)
Nasdaq
19,003.65
+31.23(+0.16%)
Russell 2000
2,406.67
+42.65(+1.80%)
Crude Oil
71.18
+1.08(+1.54%)
Gold
2,718.20
+43.30(+1.62%)

Privia Health Group, Inc. (PRVA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

21.56

+0.48

(+2.28%)

At close: 04:00PM EST

21.56

0.00

(0.00%)

After hours:

04:02PM EST

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	2.59B
Enterprise Value	2.17B
Trailing P/E	196.00
Forward P/E	32.68
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	1.57
Price/Book (mrq)	4.21
Enterprise Value/Revenue	1.27
Enterprise Value/EBITDA	106.64

Trading Information

Stock Price History

Beta (5Y Monthly)	0.76
52-Week Change ³	-1.73%
S&P500 52-Week Change ³	31.18%
52 Week High ³	24.30
52 Week Low ³	15.92
50-Day Moving Average ³	18.96
200-Day Moving Average ³	18.96

Share Statistics

Avg Vol (3 month) ³	784.37k
Avg Vol (10 day) ³	608.52k
Shares Outstanding ⁵	120M
Implied Shares Outstanding ⁶	120M
Float ⁸	98.92M
% Held by Insiders ¹	10.49%
% Held by Institutions ¹	102.75%
Shares Short (Oct 31, 2024) ⁴	5.62M
Short Ratio (Oct 31, 2024) ⁴	8.39
Short % of Float (Oct 31, 2024) ⁴	7.51%
Short % of Shares Outstanding (Oct 31, 2024) ⁴	4.68%
Shares Short (prior month Sep 30, 2024) ⁴	6.24M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Sep 30, 2024

Profitability

Profit Margin	0.75%
Operating Margin (ttm)	1.33%

Management Effectiveness

Return on Assets (ttm)	0.77%
Return on Equity (ttm)	2.23%

Income Statement

Revenue (ttm)	1.72B
Revenue Per Share (ttm)	14.44
Quarterly Revenue Growth (yoy)	4.90%
Gross Profit (ttm)	N/A
EBITDA	20.36M
Net Income Avi to Common (ttm)	12.82M
Diluted EPS (ttm)	0.11
Quarterly Earnings Growth (yoy)	-37.40%

Balance Sheet

Total Cash (mrq)	422M
Total Cash Per Share (mrq)	3.52
Total Debt (mrq)	6.18M
Total Debt/Equity (mrq)	0.93%
Current Ratio (mrq)	1.78
Book Value Per Share (mrq)	5.13

Cash Flow Statement

Operating Cash Flow (ttm)	98.58M
Levered Free Cash Flow (ttm)	89.83M